Toronto-based medical imaging company MolecuLight has secured a nearly $10 million (US$7.5 million) loan from Oxford Finance LLC, a U.S. healthcare and life sciences finance firm. The proceeds will support the commercial growth of MolecuLight i:X, a real-time, handheld fluorescence imaging solution for the global wound care market. The device helps clinicians diagnose and treat chronic wounds. Founded in 2013 by CSO Ralph DaCosta, and led by CEO Anil Amlani, MolecuLight is backed by Canadian healthcare technology venture capital firm iGan Partners and other investors. Last week, MolecuLight announced the sale of its oncology business to Photonamic GmbH & Co KG.
↧